Learn more about Adult Stem Cells
In July 2013, the Midwest Stem Cell Therapy Center (MSCTC) was created by Kansas Legislature with the mission to facilitate existing research and therapy on a global level, as well as to establish a frontier for other research and therapies for patients suffering from diseases.
The law creating the center took effect on July 1, 2013. KU Medical Center Executive Vice Chancellor Douglas Girod, M.D. appointed Buddhadeb Dawn, M.D., to serve as the center's executive director. Funded initially through state appropriation, the center also operates off the generosity of donors through the University of Kansas Endowment Association. The 15-member advisory board is composed of members appointed by the governer, the House, Senate, Board of Regents and several other stakeholder entities.
Adult stem cell treatments have been used clinically to successfully treat leukemia and related bone/blood cancers using bone marrow transplantation. KU Medical Center has been involved in research using the solid part of the umbilical cord (Wharton's jelly).
In addition to KU Medical Center, other institutions around the state and in the region have also established adult stem cell research projects. With the MSCTC goal of providing adult stem cell therapy to Kansas and the surrounding region, and the establishment of its FDA registered GMP facility, the Center acts as a hub to facilitate a systematic mechanism for the translation of basic stem cell research into clinical applications. The MSCTC is also working to educate the public, as well as medical professionals about adult stem cell therapeutic options, currently available or in development, that could benefit patients in need.
In addition to bone marrow transplantation, additional therapies with adult stem cells - including organ repair - have been the focus of intense attention in the scientific community in recent years.
As adult stem cell therapy is becoming more effective, many patients will benefit. Kansas is well-positioned to contribute to this burgeoning new field of medicine. The state has the opportunity to focus on development of specific areas of adult stem cell research and patient treatment, with the potential to become a world leader in patient therapies for specific diseases or conditions.